Literature DB >> 10946320

Cellular and molecular mechanism for Kilham rat virus-induced autoimmune diabetes in DR-BB rats.

Y H Chung1, H S Jun, M Son, M Bao, H Y Bae, Y Kang, J W Yoon.   

Abstract

Kilham rat virus (KRV) causes autoimmune diabetes in diabetes-resistant BioBreeding (DR-BB) rats; however, the mechanism by which KRV induces autoimmune diabetes without the direct infection of beta cells is not well understood. We first asked whether molecular mimicry, such as a common epitope between a KRV-specific peptide and a beta cell autoantigen, is involved in the initiation of KRV-induced autoimmune diabetes in DR-BB rats. We found that KRV peptide-specific T cells generated in DR-BB rats infected with recombinant vaccinia virus expressing KRV-specific structural and nonstructural proteins could not induce diabetes, indicating that molecular mimicry is not the mechanism by which KRV induces autoimmune diabetes. Alternatively, we asked whether KRV infection of DR-BB rats could disrupt the finely tuned immune balance and activate autoreactive T cells that are cytotoxic to beta cells, resulting in T cell-mediated autoimmune diabetes. We found that both Th1-like CD45RC+CD4+ and cytotoxic CD8+ T cells were up-regulated, whereas Th2-like CD45RC-CD4+ T cells were down-regulated, and that isolated and activated CD45RC+CD4+ and CD8+ T cells from KRV-infected DR-BB rats induced autoimmune diabetes in young diabetes-prone BioBreeding (DP-BB) rats. We conclude that KRV-induced autoimmune diabetes in DR-BB rats is not due to molecular mimicry, but is due to a breakdown of the finely tuned immune balance of Th1-like CD45RC+CD4+ and Th2-like CD45RC-CD4+ T cells, resulting in the selective activation of beta cell-cytotoxic effector T cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10946320     DOI: 10.4049/jimmunol.165.5.2866

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  VP2 capsid domain of the H-1 parvovirus determines susceptibility of human cancer cells to H-1 viral infection.

Authors:  I-R Cho; S Kaowinn; J Song; S Kim; S S Koh; H-Y Kang; N-C Ha; K H Lee; H-S Jun; Y-H Chung
Journal:  Cancer Gene Ther       Date:  2015-04-10       Impact factor: 5.987

2.  Prevention of adjuvant arthritis by the W3/25 anti-CD4 monoclonal antibody is associated with a decrease of blood CD4(+)CD45RC(high) T cells.

Authors:  C Pelegrí; M Castell; M Serra; M Rabanal; M Rodríguez-Palmero; C Castellote; A Franch
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

Review 3.  Prevention or acceleration of type 1 diabetes by viruses.

Authors:  Liana Ghazarian; Julien Diana; Yannick Simoni; Lucie Beaudoin; Agnès Lehuen
Journal:  Cell Mol Life Sci       Date:  2012-07-06       Impact factor: 9.261

4.  Immune responses to the major capsid protein during parvovirus infection of rats.

Authors:  Lisa J Ball-Goodrich; Frank X Paturzo; Elizabeth A Johnson; Krista Steger; Robert O Jacoby
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

Review 5.  Visceral Adipose Tissue: A New Target Organ in Virus-Induced Type 1 Diabetes.

Authors:  Danny Zipris
Journal:  Front Immunol       Date:  2021-08-04       Impact factor: 7.561

Review 6.  Immune System Stimulation by Oncolytic Rodent Protoparvoviruses.

Authors:  Assia Angelova; Jean Rommelaere
Journal:  Viruses       Date:  2019-05-04       Impact factor: 5.048

7.  Type I IFN-Driven Immune Cell Dysregulation in Rat Autoimmune Diabetes.

Authors:  Natasha Qaisar; Adediwura Arowosegbe; Alan G Derr; Alper Kucukural; Basanthi Satish; Riccardo Racicot; Zhiru Guo; Melanie I Trombly; Jennifer P Wang
Journal:  Immunohorizons       Date:  2021-10-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.